Slideshow
Author(s):
New research highlights prevention, diagnostic, and treatment advances for Alzheimer, autism, atherosclerosis, and more.
GLP-1 Agonists and SGLT2 Inhibitors Considered More Effective for Lowering Alzheimer Disease Risk
Special Episode: What Apomorphine Infusion Approval Means for Parkinson Disease Care
Exploring a New Oral Option for Alzheimer Treatment With Sonya Miller
Episode 132: Aiding Diagnosis of Synucleinopathies Through SAAmplify-aSYN Biomarker Test
How Personalized Repetitive Transcranial Magnetic Stimulation May Transform Alzheimer Treatment
NeurologyLive® Friday 5 — April 18, 2025